Related Experiment Videos

An international serotyping system for Clostridium perfringens (welchii) type A in the near future

Developments in Biological Standardization
|January 1, 1976
PubMed

Insights

Clostridium perfringens type A causes infections and food poisoning. A new international serotyping scheme using antisera will improve understanding of its epidemiology.

Area of Science:

  • Microbiology
  • Immunology
  • Epidemiology

Background:

  • Clostridium perfringens type A is a significant cause of human clinical infections and foodborne illness.
  • Current typing methods for Clostridium perfringens type A lack the necessary granularity for detailed epidemiological studies.
  • There is a recognized need for refined classification within the type A group to better understand disease transmission.

Purpose of the Study:

  • To develop and implement a comprehensive, internationally recognized serotyping scheme for Clostridium perfringens type A.
  • To enhance the epidemiological surveillance of Clostridium perfringens type A infections and food poisoning.
  • To facilitate a deeper understanding of the global distribution and transmission dynamics of Clostridium perfringens type A.

Main Methods:

  • Development and validation of a specific set of antisera for Clostridium perfringens type A subtyping.
  • Integration of independently developed antisera from the USA and Japan with existing Food Hygiene Laboratory reagents.
  • Establishment of a collaborative international effort to standardize serotyping procedures.

Main Results:

  • A valuable set of antisera has been developed, proving effective for Clostridium perfringens type A subtyping.
  • The developed antisera are being integrated with international counterparts to create a unified serotyping scheme.
  • Negotiations for commercial production of key antisera are underway, indicating progress towards wider availability.

Conclusions:

  • The establishment of an international serotyping scheme for Clostridium perfringens type A is nearing completion.
  • Improved serotyping facilities will soon be accessible to researchers globally.
  • This advancement is expected to significantly enhance the study and control of Clostridium perfringens type A-related diseases.

Related Concept Videos